Valiant Organics Limited · NSE:VALIANTORG
Valiant Organics — Q4 FY2026 Earnings Presentation
24 slides from Valiant Organics's earnings presentation, May 27, 2026
Slide 1: Stock exchange cover letter: Investors Presentation
May 27, 2026 To, To, Listing / Compliance Department Listing / Compliance Department BSE LTD National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1, Dalal Street, G Block Bandra-Kurla, Complex, Bandra (E), Mumbai- 400 001. Mumbai- 400 051. CODE-540145 SYMB
Slide 2: Earnings Presentation | Q4/FY26
Earnings Presentation | Q4/FY26-FY26
Slide 3: Snapshot
SNAPSHOT One of the largest chlorophenol One of the leading manufacturer of derivatives manufacturer globally Benzene derivatives products One of the largest domestic PNA One of the few commercial players in manufacturer Ortho Anisidine and Para Anisidine Diversified client base across Amongst 1st f
Slide 4: Company Overview
Company Overview Valiant Organics Limited was incorporated in 1984 by first generation technocrats and is headquartered out of Mumbai, India. The company is focused on the manufacturing and marketing of specialty chemicals which find usage in a variety of industries, including agrochemicals, pharmac
Slide 5: Chemistries And Product Basket
Chemistries And Product Basket FY26 Revenue Share Hydrogenation Ammonolysis 48% Key Products: Industries Served: Key Products: • Ortho Anisidine Industries Served: • Dyes • Para Nitro Aniline • Para Anisidine • Dyes • Pigments • Ortho Chloro Para Nitro Aniline • IPPCA • Pigments • Pharmaceutical • M
Slide 6: Manufacturing Footprint
Manufacturing Footprint CHLORINATION – SARIGAM HYDROGENATION & METHOXYLATION- • Capacity: 18,000 MTPA JHAGADIA UNIT 1 • Products: PCP, OCP, 2,4 DCP, 2,6 DCP, • Capacity: 28,800 MTPA 2,4,6 TCP • Products: ONA/OA, PNA/PA, IPPCA, CONVERSION PRODUCTS AMMONOLYSIS - VAPI HYDROGENATION – JHAGADIA UNIT 2 •
Slide 7: Key Strengths
Key Strengths Domain expertise and broad Plant locations are process understanding in a Wide supply chain strategically located near variety of chemistries. The provides the continuous ports to provide a executive team is made up of availability of adequate competitive advantage, first-generation te
Slide 8: Q4/FY26 Highlights
Q4/FY26-FY26 HIGHLIGHTS Valiant Organics Limited | Q4-2026 7
Slide 9: Consolidated Financial Highlights
CONSOLIDATED FINANCIAL HIGHLIGHTS Q4-FY26 CONSOLIDATED FINANCIAL HIGHLIGHTS FY26 CONSOLIDATED FINANCIAL HIGHLIGHTS INR 2,178 Mn INR 7,388 Mn Operational Revenue Operational Revenue INR 265 Mn INR 882 Mn Operating EBITDA Operating EBITDA 12.17% 11.94% Operating EBITDA Margin Operating EBITDA Margin I
Slide 10: Q4-FY26/FY26 Operational Highlights
Q4-FY26/FY26 Operational Highlights Q4-FY26 Revenue Break-up – Chemistries • FY2025-26 marked a significant turnaround year for the Company, driven by focused Others, 7% operational execution and structural cost optimization initiatives. • Revenue for the year increased by 3% year-on-year to INR 7,3
Slide 11: Key Chemistries: Revenues and Sales Volumes
Key Chemistries Chlorination (INR Mn) Hydrogenation (INR Mn) Ammonolysis (INR Mn) Others (INR Mn) 1,200 1,126 1,050 600 533 180 163 440 431 1,000 458 160 REVENUES 420 413 500 429 140 800 672 400 120 400 100 93 600 300 362 380 80 360 400 200 60 42 40 200 100 340 20 0 0 320 - Q4-FY25 Q3-FY26 Q4-FY26 Q
Slide 12: Quarterly Consolidated Financial Performance
Quarterly Consolidated Financial Performance Particulars (INR Mn) Q4-FY26 Q4-FY25 Y-o-Y Q3-FY26 Q-o-Q Revenue from Operations 2,178 2,038 6.9% 1,593 36.7% Total Expenses 1,913 1,835 4.3% 1,437 33.1% EBITDA 265 203 30.5% 156 69.9% EBITDA Margins (%) 12.17% 9.96% 221 Bps 9.79% 238 Bps Other Income 40
Slide 13: Annual Consolidated Financial Performance
Annual Consolidated Financial Performance Particulars (INR Mn) FY26 FY25 Y-o-Y Revenue from Operations 7,388 7,188 2.8% Total Expenses 6,506 6,651 (2.2)% EBITDA 882 537 64.2% EBITDA Margins (%) 11.94% 7.47% 447 Bps Other Income 69 86 (19.8)% Depreciation 396 358 10.6% Finance Cost 182 236 (22.9)% PB
Slide 14: Quarterly Standalone Financial Performance
Quarterly Standalone Financial Performance Particulars (INR Mn) Q4-FY26 Q4-FY25 Y-o-Y Q3-FY26 Q-o-Q Revenue from Operations 2,177 2,038 6.8% 1,591 36.8% Total Expenses 1,912 1,835 4.2% 1,435 33.2% EBITDA 265 203 30.5% 156 69.9% EBITDA Margins (%) 12.17% 9.96% 221 Bps 9.81% 236 Bps Other Income 40 7
Slide 15: Annual Standalone Financial Performance
Annual Standalone Financial Performance Particulars (INR Mn) FY26 FY25 Y-o-Y Revenue from Operations 7,384 7,188 2.7% Total Expenses 6,502 6,651 (2.2)% EBITDA 882 537 64.2% EBITDA Margins (%) 11.94% 7.47% 447 Bps Other Income 69 81 (14.8)% Depreciation 396 358 10.6% Finance Cost 182 236 (22.9)% PBT
Slide 16: Historical Financial Overview
HISTORICAL FINANCIAL OVERVIEW Valiant Organics Limited | Q4-2026 15
Slide 17: Historical Consolidated Income Statement
Historical Consolidated Income Statement Particulars (INR Mn) FY23 FY24 FY25 FY26 Revenue from Operations 10,518 7,231 7,188 7,388 Total Expenses 8,875 6,849 6,651 6,506 EBITDA 1,643 382 537 882 EBITDA Margins (%) 15.62% 5.28% 7.47% 11.94% Other Income 80 93 86 69 Depreciation 292 349 358 396 Financ
Slide 18: Historical Consolidated Balance Sheet
Historical Consolidated Balance Sheet Particulars (INR Mn) FY24 FY25 FY26 Particulars (INR Mn) FY24 FY25 FY26 EQUITY 7,293 7,253 7,594 Non-Current Assets 8,352 8,269 8,786 a) Equity Share Capital 276 280 280 a) Property, Plant and Equipment 6,297 6,437 6,791 b) Other Equity 7,017 6,973 7,314 c) Righ
Slide 19: Historical Standalone Income Statement
Historical Standalone Income Statement Particulars (INR Mn) FY23 FY24 FY25 FY26 Revenue from Operations 9,116 6,772 7,188 7,384 Total Expenses 7,817 6,376 6,651 6,502 EBITDA 1,299 396 537 882 EBITDA Margins (%) 14.25% 5.85% 7.47% 11.94% Other Income 29 29 81 69 Depreciation 276 340 358 396 Finance C
Slide 20: Historical Standalone Balance Sheet
Historical Standalone Balance Sheet Particulars (INR Mn) FY24 FY25 FY26 Particulars (INR Mn) FY24 FY25 FY26 EQUITY 6,649 6,616 6,969 Non-Current Assets 7,818 7,750 7,793 a) Equity Share Capital 276 280 280 a) Property, Plant and Equipment 6,297 6,437 6,791 b) Other Equity 6,373 6,336 6,689 b) Right-
Slide 21: Consolidated Financial Highlights
Consolidated Financial Highlights Operational Revenue (INR Mn) EBITDA (INR Mn) & EBITDA Margins (%) PAT (INR Mn) & PAT Margins (%) 1,400 10,518 10,000 1,643 1,100 1,026 17.00% 7,231 7,188 7,388 7,500 9.75% 800 12.00% 882 5,000 537 500 332 15.62% 382 7.00% 11.94% 4.49% 2,500 5.28% 7.47% 200 - 2.00% -
Slide 22: Capital Market Information
Capital Market Information Share Price up to 31st March, 2026 90% 70% 50% 30% 10% -10% -30% -50% -70% Apr-25 May-25 Jun-25 Jul-25 Aug-25 Sep-25 Oct-25 Nov-25 Dec-25 Jan-26 Feb-26 Mar-26 Valiant Organics Sensex Price Data (As of 31st March 2026) INR Shareholding pattern (As of 31st March, 2026) Face
Slide 23: Disclaimer
Disclaimer Valiant Organics Limited No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all event
Slide 24: Thank You
THANK YOU Valiant Organics Limited | Q4-2026 23